Skip to main content

Table 3 Number of patients who developed cardiovascular events for 3 years before and after the beginning of the study

From: Estimated influence of a novel biocompatible dialysis membrane on vascular events in dialysis patients with diabetic nephropathy: a prospective randomized controlled pilot study

Group

 

− 3 to − 2 year

− 2 to − 1 year

− 1 to 0 year

0 to 1 year

1 to 2 years

2 to 3 years

Total (0 to 3 years)

NV group

n

15

15

15

15

15

15

45

Yes

4

5

3

4

4

5

13

No

11

10

12

11

11

10

32

PS group

n

15

15

15

15

15

15

45

Yes

1

4

3

5

4

5

14

No

14

11

12

10

11

10

31

  1. Yes, number of patients who developed cardiovascular events; no, number of patients who did not develop cardiovascular events
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us